Search research articles
Contact Us
Filters
Showing results (571-580 of 709) with videos related to
Page
of 71
Sort By:
International Journal of Cancer
|
January 6, 2011
The spectrum of malignancies in HIV-infected patients in 2006 in France: the ONCOVIH study
Emilie Lanoy, Jean-Philippe Spano, Fabrice Bonnet, et al.
The European Respiratory Journal
|
February 16, 2018
Immunotherapy: a new standard of care in thoracic malignancies? A summary of the European Respiratory Society research seminar of the Thoracic Oncology Assembly
Adrien Costantini, Marta Grynovska, Francesca Lucibello, et al.
Pharmaceutics
|
September 23, 2022
Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer
Thomas Rodier, Alicja Puszkiel, Evelina Cardoso, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
May 26, 2017
Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents (Update 2016)
Nicola L Jones, Sibylle Koletzko, Karen Goodman, et al.
Advances in Therapy
|
November 10, 2021
Treatment of Idiopathic Pulmonary Fibrosis with Capsule or Tablet Formulations of Pirfenidone in the Real-Life French RaDiCo-ILD Cohort
Vincent Cottin, Sonia Guéguen, Hilario Nunes, et al.
Respiratory Medicine and Research
|
June 22, 2020
Proposals for managing patients with thoracic malignancies during COVID-19 pandemic
N Girard, L Greillier, G Zalcman, et al.
World Journal of Hepatology
|
April 5, 2013
Low incidence of spontaneous bacterial peritonitis in asymptomatic cirrhotic outpatients
Jean-François Cadranel, Jean-Baptiste Nousbaum, Christophe Bessaguet, et al.
Cancers
|
April 3, 2021
Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients
Valérie Gounant, Michael Duruisseaux, Ghassen Soussi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 28, 2018
c-MET Overexpression as a Poor Predictor of MET Amplifications or Exon 14 Mutations in Lung Sarcomatoid Carcinomas
Xavier Mignard, Anne-Marie Ruppert, Martine Antoine, et al.
Cancers
|
April 12, 2022
Brigatinib for Pretreated, ALK-Positive, Advanced Non-Small-Cell Lung Cancers: Long-Term Follow-Up and Focus on Post-Brigatinib Lorlatinib Efficacy in the Multicenter, Real-World BrigALK2 Study
Renaud Descourt, Maurice Pérol, Gaëlle Rousseau-Bussac, et al.
Page
of 71
Search research articles
Search
Showing results (571-580 of 709) with videos related to
Sort By:
Page
of 71
International Journal of Cancer
|
January 6, 2011
The spectrum of malignancies in HIV-infected patients in 2006 in France: the ONCOVIH study
Emilie Lanoy, Jean-Philippe Spano, Fabrice Bonnet, et al.
The European Respiratory Journal
|
February 16, 2018
Immunotherapy: a new standard of care in thoracic malignancies? A summary of the European Respiratory Society research seminar of the Thoracic Oncology Assembly
Adrien Costantini, Marta Grynovska, Francesca Lucibello, et al.
Pharmaceutics
|
September 23, 2022
Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer
Thomas Rodier, Alicja Puszkiel, Evelina Cardoso, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
May 26, 2017
Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents (Update 2016)
Nicola L Jones, Sibylle Koletzko, Karen Goodman, et al.
Advances in Therapy
|
November 10, 2021
Treatment of Idiopathic Pulmonary Fibrosis with Capsule or Tablet Formulations of Pirfenidone in the Real-Life French RaDiCo-ILD Cohort
Vincent Cottin, Sonia Guéguen, Hilario Nunes, et al.
Respiratory Medicine and Research
|
June 22, 2020
Proposals for managing patients with thoracic malignancies during COVID-19 pandemic
N Girard, L Greillier, G Zalcman, et al.
World Journal of Hepatology
|
April 5, 2013
Low incidence of spontaneous bacterial peritonitis in asymptomatic cirrhotic outpatients
Jean-François Cadranel, Jean-Baptiste Nousbaum, Christophe Bessaguet, et al.
Cancers
|
April 3, 2021
Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients
Valérie Gounant, Michael Duruisseaux, Ghassen Soussi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 28, 2018
c-MET Overexpression as a Poor Predictor of MET Amplifications or Exon 14 Mutations in Lung Sarcomatoid Carcinomas
Xavier Mignard, Anne-Marie Ruppert, Martine Antoine, et al.
Cancers
|
April 12, 2022
Brigatinib for Pretreated, ALK-Positive, Advanced Non-Small-Cell Lung Cancers: Long-Term Follow-Up and Focus on Post-Brigatinib Lorlatinib Efficacy in the Multicenter, Real-World BrigALK2 Study
Renaud Descourt, Maurice Pérol, Gaëlle Rousseau-Bussac, et al.
Page
of 71